Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06930508 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bringing Medicines for HIV Prevention to a Family Planning Clinic

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Jul 31, 2026 → Oct 31, 2026
See other at-risk trials from Women and Infants Hospital of Rhode Island

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 31, 2026 to Oct 31, 2026
    • Study completion pushed from Jul 31, 2026 to Dec 31, 2026
    v5
  2. Recruitment opened
    • Primary and study completion pushed from Jun 30, 2026 to Jul 31, 2026
    • Start date changed from estimate of Jun 1, 2026 to May 28, 2026
    • Site details revised
    v4
  3. Start date: Mar 15, 2026 to Jun 1, 2026v3
  4. Start date: Jul 1, 2025 to Mar 15, 2026
    • Primary endpoints: 2 to 3
    • Primary completion date: Feb 28, 2026 to Jun 30, 2026
    • Secondary endpoints shortened, about 2 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: 1. Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic? 2. What things make it easier or harder to ask about PrEP in a family planning clinic setting? 3. What things make it easier or harder to begin PrEP in a family planning clinic setting? Patient participants: 1. Will receive standardized counseling about PrEP. 2. Will have the opportunity to begin PrEP as part of their routine, ongoing care. 3. Will be asked to complete a survey about their experiences. Physician participants: 1. Will receive standardized education about PrEP. 2. Will talk to patient participants about PrEP, and support patient participants who want to begin PrEP. 3. Will be asked to complete pre-and post-study surveys about their experiences. 4. May be asked to complete a post-study in-depth interview about their experiences.
Trial Details
NCT Number NCT06930508
Lead Sponsor Women and Infants Hospital of Rhode Island
Collaborators: Advance RI CTR
Conditions
(from sponsor)		 HIV, PrEP
Enrollment 83 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov